$60,000 of BECTON DICKINSON AND COMPANY lobbying was just disclosed, from Q3 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Provide strategic counsel and advocate on issues related to medical device regulation."
You can find more data on corporate lobbying on Quiver Quantitative.
BDX Congressional Stock Trading
Members of Congress have traded $BDX stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $BDX stock by members of Congress over the last 6 months:
- REPRESENTATIVE THOMAS H. KEAN, JR. sold up to $15,000 on 05/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
BDX Insider Trading Activity
BDX insiders have traded $BDX stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales.
Here’s a breakdown of recent trading of $BDX stock by insiders over the last 6 months:
- THOMAS E JR POLEN (Chairman, CEO and President) has made 0 purchases and 2 sales selling 6,916 shares for an estimated $1,172,631.
- ROLAND GOETTE (EVP and President, EMEA) sold 2,438 shares for an estimated $440,887
- MICHAEL DAVID GARRISON (EVP & Pres Med.Essntl&BioPharm) has made 0 purchases and 2 sales selling 2,200 shares for an estimated $326,854.
- MICHAEL FELD (EVP, Chief Revenue Officer) has made 0 purchases and 6 sales selling 540 shares for an estimated $90,601.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
BDX Hedge Fund Activity
We have seen 661 institutional investors add shares of BDX stock to their portfolio, and 674 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 6,503,791 shares (-63.6%) from their portfolio in Q2 2026, for an estimated $984,218,692
- GREENHAVEN ASSOCIATES INC added 5,681,708 shares (+inf%) to their portfolio in Q2 2026, for an estimated $859,812,871
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 3,398,203 shares (+inf%) to their portfolio in Q2 2026, for an estimated $514,250,059
- JPMORGAN CHASE & CO added 2,835,692 shares (+inf%) to their portfolio in Q2 2026, for an estimated $429,125,270
- FRANKLIN RESOURCES INC added 1,648,627 shares (+30.7%) to their portfolio in Q2 2026, for an estimated $249,486,723
- NORDEA INVESTMENT MANAGEMENT AB removed 1,645,716 shares (-67.6%) from their portfolio in Q2 2026, for an estimated $249,046,202
- BLACKROCK, INC. removed 1,561,245 shares (-6.0%) from their portfolio in Q2 2026, for an estimated $236,263,205
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
BDX Price Targets
Multiple analysts have issued price targets for $BDX recently. We have seen 4 analysts offer price targets for $BDX in the last 6 months, with a median target of $171.5.
Here are some recent targets:
- Vijay Kumar from Evercore ISI Group set a target price of $180.0 on 07/06/2026
- Matt Miksic from Barclays set a target price of $204.0 on 05/11/2026
- Lawrence Biegelsen from Wells Fargo set a target price of $161.0 on 05/08/2026
- Joshua Jennings from TD Cowen set a target price of $163.0 on 05/04/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
